Background
==========

Stroke is the most common cerebrovascular disease and is a leading cause of death and disability all over the world \[[@b1-medscimonit-26-e919110]\]. Intracerebral hemorrhage (ICH) is a primary subtype of stroke, and its incidence and fatality rates are increasing \[[@b2-medscimonit-26-e919110]\]. It is defined as hemorrhage caused by blood extravasation into the brain parenchyma. ICH pathogenesis is complicated and involves environmental and genetic components. The major modifiable risk factors are smoking, heavy alcohol intake, advanced age, hypertension, and diabetes, but they do not explain all cases of ICH \[[@b3-medscimonit-26-e919110]--[@b5-medscimonit-26-e919110]\], and genetic components in ICH are being increasingly studied \[[@b6-medscimonit-26-e919110],[@b7-medscimonit-26-e919110]\].

Endothelin-1 (END1), encoded by the *EDN1* gene located on chromosome 6 (6p21--24), is a potent and long-lasting vasoconstrictor produced by endothelial cells of the vasculature, and it acts as a modulator of vasomotor tone and vascular remodeling \[[@b8-medscimonit-26-e919110],[@b9-medscimonit-26-e919110]\]. Animal experiments demonstrated that the knockdown of *EDN1* in mice can cause hypertension, thus leading to cerebrovascular diseases \[[@b10-medscimonit-26-e919110]\]. *EDN1* is expressed in some tissues and cells, such as endothelial cells and cardiomyocytes \[[@b11-medscimonit-26-e919110]\]. Additionally, it has proatherogenic activity and regulates smooth-muscle cell proliferation through *EDN1* receptors. Furthermore, *EDN-1* causes the alteration of vascular structure and function in resistance vessels and acts as a proinflammatory factor in heart failure \[[@b12-medscimonit-26-e919110]\]. It has been demonstrated that *EDN1* has a number of polymorphisms involved in hypertension \[[@b13-medscimonit-26-e919110]\], body mass index \[[@b14-medscimonit-26-e919110]\], coronary heart disease \[[@b15-medscimonit-26-e919110]\], and ischemic stroke \[[@b16-medscimonit-26-e919110]\]. In aneurysmal subarachnoid hemorrhage patients, *EDN1* rs2070699 polymorphism was reported to be an independent risk indicator for aneurysm rebleeding \[[@b17-medscimonit-26-e919110]\]. Moreover, *EDN1* rs6912834 polymorphism is associated with angiographic vasospasm in aneurysmal subarachnoid hemorrhage patients \[[@b18-medscimonit-26-e919110]\]. In addition, the genetic association of *EDN1* polymorphism with the risk of neonatal intraventricular hemorrhage (IVH) was also reported in preterm infants in a white population \[[@b19-medscimonit-26-e919110]\]. Few published reports mention the correlation of *EDN1* polymorphisms with ICH susceptibility among Chinese Han people.

Therefore, we explored the possible association of *EDN1* variants with susceptibility of individuals to ICH among Chinese Han people. We selected 2 common polymorphisms in *EDN1* -- rs5370 and rs6458155.

Material and Methods
====================

Study participants
------------------

Our research was approved by the Ethics Committee of Harrison International Peace Hospital, and written informed consent was obtained from participants or their family members before sampling.

The case group consisted of a cohort of 154 consecutive ICH patients treated at the Neurology Department of Harrison International Peace Hospital. All included cases were confirmed based on their clinical features and computed tomography (CT) or/and magnetic resonance imaging (MRI) examination. Exclusion criteria for the case group were ICH resulting from trauma, neoplasms, anticoagulant therapy, coagulation disorders, aneurysms, and vascular malformations. The control group consisted of 168 healthy people seen at the health examination center of the same Hospital during the same period. Exclusion criteria for the control group included history of heart or vessel disorders, previous stroke incidents, and malignancy. Clinical characteristics for enrolled participants were investigated and documented by experienced doctors, including age, sex, body mass index (BMI), presence or absence of hypertension, ischemic heart disease and diabetes, alcohol intake, and current smoking. All enrolled subjects were unrelated Han Chinese people.

Genotyping
----------

Firstly, 2 ml of peripheral blood was drawn from every participant in the morning after a 12-h fast into a blood-collection tube containing EDTA, and maintained at −80°C. Genomic DNA of peripheral blood samples was isolated by phenol-chloroform method. The integrity of DNA was verified by 1% agarose gel electrophoresis. Its purity and concentration were assessed using spectrophotometry in a Nanodrop 2000c device (Thermo Scientific, Suwanee, GA, USA).

Polymerase chain reaction-direct sequencing (PCR-DS) was used for the genotyping of *EDN1* rs5370 and rs6458155 polymorphisms. PCR primers of polymorphism were designed using Primer Premier 5.0 software and were generated by Shanghai Sangon Bio. Co. (Sangon, Shanghai). The specific primers of rs5370 and rs6458155 were:

1.  rs5370 forward: 5′-TCTTTTGCCAAAGGGTGATT-3′,

2.  reverse: 5′-CAGGGTGGAGAGTGCAGAG-3′;

3.  rs6458155: forward: 5′-AAGGCTGTGTGGGAGATGAG-3′,

4.  reverse: 5′-CTTCTGGAAACCCTGCTCTG-3′.

The PCR system consisted of 25.0 μl mixed solution, including 20 ng DNA template, 12.5 μl PCR Master Mix, each 1.0 μl of forward and reverse primers and ddH~2~O added to achieve a final volume. The PCR procedure was: 95°C for 3 min for pre-degeneration, 35 cycles of 94°C for 60 s for degeneration, 61°C or 57°C for 60 s for annealing, 72°C for 45 s for extension, and final extension at 72°C for 7 min, then stored at 4°C.

Acceptable PCR products were sent to Shanghai Sangon Bio. Co. for sequencing to determine genotypes for polymorphisms for all subjects.

Statistical analysis
--------------------

Data synthesis was carried out with SPSS 18.0 software (SPSS, Inc., Chicago, IL, USA). Hardy-Weinberg equilibrium (HWE) status was checked in the control group by chi-square text. Categorical data are presented as numbers and proportions, while continuous data are presented as mean±SD (standard deviation). In subsequent analysis, the comparisons between cases and controls were analyzed using the *t* test. Genotype and allele frequencies for polymorphisms between ICH cases and healthy control subjects were compared using the chi-square test. The strength of associations between polymorphisms and ICH susceptibility was assessed by calculating odds ratio (OR) and 95% confidence interval (CI). Logistic regression analysis was applied to adjust the results by considering confounding factors. *P*\<0.05 indicated a statistically significant difference.

Results
=======

Basic features of study participants
------------------------------------

[Table 1](#t1-medscimonit-26-e919110){ref-type="table"} lists demographic and clinical information of study participants. The mean onset age of ICH patients was 50.92±5.91 years old. There were 137 ICH patients confirmed as having symptomatic intracerebral hemorrhage (SICH), while the other 17 patients were diagnosed with asymptomatic intracerebral hemorrhage (aSICH). Comparison analyses demonstrated that there was no significant dissimilarity between the 2 groups in age (*P*=0.618), sex (*P*=0.376), or BMI (body mass index) (*P*=0.212). However, in the case group there were significantly more ICH patients with hypertension (*P*\<0.001), ischemic heart disease (*P*\<0.001), and diabetes (*P*=0.001) than in the control group. Moreover, alcohol intake between cases and controls was also significantly different (*P*\<0.001). For current smokers, no obvious difference was found between the 2 groups (*P*=0.434).

Connection for *EDN1* variants to ICH risk
------------------------------------------

As shown in [Figure 1](#f1-medscimonit-26-e919110){ref-type="fig"}, the genotypes of *EDN1* polymorphisms were identified by direct sequencing. [Table 2](#t2-medscimonit-26-e919110){ref-type="table"} shows the genotype and allele distribution for *EDN1* variants among the 2 groups. Genotype distributions for rs5370 and rs6458155 polymorphisms in the control group both conformed to Hardy-Weinberg equilibrium, indicating that the study group was from the same Mendelian genetic population (*P*\>0.05).

GT and TT genotypes of rs5370 were more frequent among cases than among controls, but the difference was not statistically significant. Similar results were observed in the allele distribution of rs5370 (*P*\>0.05). Following adjusted by age, sex and BMI, the results were not obviously changed (adjusted *P*\>0.05). However, CC genotype of rs6458155 in cases was more frequent than in controls (*P*=0.025). Similarly, its C allele was also significantly higher in the case group than in controls (*P*=0.043). Therefore, CC genotype and C allele of rs6458155 increased ICH risk (CC *vs*. TT: OR=2.214, 95% CI=1.099--4.461; C *vs*. T: OR=1.389, 95% CI=1.010--1.910). Moreover, after adjustment for age, sex, and BMI, the significant differences still existed (CC *vs*. TT: adjusted OR=2.217, 95% CI=1.092--4.500, *P*=0.028; C *vs*. T: adjusted OR=1.386, 95% CI=1.005--1.910, *P*=0.046).

Discussion
==========

ICH is a common type of stroke and is also considered to be a multifactorial disorder involving environmental and genetic elements. A number of factors have been reported to be associated with ICH occurrence, such as hypertension, cardiac disease, diabetes, and alcohol intake. However, few people exposed to these factors develop ICH. Therefore, genetic factors are the most important influences on ICH etiology. Therefore, to predict individual and population susceptibility and explore the pathological mechanism of ICH occurrence, it is of great importance to assess the polymorphisms that affect gene function or expression and which are associated with ICH risk. Most patients with ICH have elevated blood pressure, and studies have indicated that the genetic predisposition to high blood pressure can explain much of the genetic susceptibility to ICH \[[@b20-medscimonit-26-e919110]\].

*EDN1* is the most potent vasoconstrictor and mediates the 2-way effect of contraction after relaxation in endothelium-intact vessels through binding endothelin receptor. It is also reported to be related to vascular tone and blood pressure modulation \[[@b21-medscimonit-26-e919110]\]. Various polymorphisms in *EDN1* have been confirmed and they have been investigated in a number of vascular conditions, such as essential hypertension \[[@b22-medscimonit-26-e919110]\], preeclamptic pregnancy \[[@b23-medscimonit-26-e919110]\], and cerebral small-vessel disease \[[@b24-medscimonit-26-e919110]\]. Among them, rs5370 is a widely studied polymorphism located on the exon5 region of *EDN1*, causing the substitution of guanine/thymine. It can alter the function of EDN1 in humans \[[@b25-medscimonit-26-e919110]\]. Schiffrin et al. revealed that *EDN1* acts as a central pivot in the process of elevated blood pressure and vascular proliferation \[[@b26-medscimonit-26-e919110]\]. Zhang et al. showed that *EDN1* rs5370 and rs2070699 polymorphisms are risk factors for ischemic stroke in the male Han population in northern China \[[@b27-medscimonit-26-e919110]\]. Carlos et al. found that the paternal rs5370 polymorphism in *EDN1* is associated with reduced risk of preeclampsia \[[@b28-medscimonit-26-e919110]\]. Rs6458155, a mutation in 5′UTR of *EDN1* inducing the replacement of C/T, has been reported to influence transcriptional activity of *EDN1* and change the concentration of circulating ET-1 \[[@b15-medscimonit-26-e919110]\]. Therefore, *EDN1* rs6458155 and rs5370 polymorphisms were selected to study the association with ICH risk.

In the present study, we analyzed the potential function of *EDN1* polymorphisms in the occurrence and development of ICH in a Chinese Han population. Significant associations were detected between ICH occurrence and hypertension, ischemic heart disease, diabetes, and alcohol intake. We also found that carrying the CC genotype and C allele in the *EDN1* rs6458155 polymorphism significantly increased the risk of ICH compared with TT genotype and T allele carries in the Chinese Han population. After adjustment for confounding factors, CC genotype and C allele of rs6458155 were associated with 2.217-fold and 1.386-fold, respectively, higher ICH risk compared with the corresponding controls. However, no significant correlation was observed between rs5370 and ICH susceptibility. Our findings are consistent with previous studies. For instance, Liang et al. demonstrated that rs6458155 polymorphism in the *EDN1* gene can affect susceptibility to coronary artery disease among Chinese Han people \[[@b15-medscimonit-26-e919110]\]. A study by Fang et al. found no independent association between *EDN1* rs5370 or rs10478694 polymorphisms and risk of developing hypertension in the Chinese population \[[@b22-medscimonit-26-e919110]\].

Although our study produced important results, several limitations should be considered. First, the sample size was relatively small, which could lead to low statistical power for identifying differences between the 2 groups. Second, the study population was homogenous and only included Chinese Han people, but because the distribution of polymorphisms differs with ethnicity, the accuracy of our data is limited. Third, ICH is influenced by a variety of factors, but we did not perform detailed analysis of gene-gene and gene-environment interactions. Consequently, future research should have larger sample sizes, include various ethnic groups, and considering more environmental factors.

Conclusions
===========

Our findings show that *EDN1* rs6458155 polymorphism may play a role in the onset of ICH in the Chinese Han population, and rs5370 was not found to be associated with risk of ICH. These findings will be valuable for future studies to research the molecular mechanism of *EDN1* polymorphisms in ICH development.

**Source of support:** Departmental sources
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###### 

Basic characteristics of ICH patients and controls.

  Characteristics          Cases (n=154, %)   Controls (n=168, %)   *P* value
  ------------------------ ------------------ --------------------- -----------
  Mean age (years±SD)      50.92±5.91         50.54±6.11            0.618
  Gender                                                            
   Male                    86                 102                   0.376
   Female                  68                 66                    
  BMI (kg/m^2^, mean±SD)   24.60±1.82         23.61±1.55            0.212
  Hypertension                                                      
   No                      90                 133                   \<0.001
   Yes                     64                 35                    
  Ischemic heart disease                                            
   Absent                  137                168                   \<0.001
   Present                 17                 0                     
  Diabetes                                                          
   Absent                  144                168                   0.001
   Present                 10                 0                     
  Alcohol intake                                                    
   Absent                  107                147                   \<0.001
   Present                 47                 21                    
  Current smoking                                                   
   Absent                  134                141                   0.434
   Present                 20                 27                    
  Pathological subtype                                              
   SICH                    137                                      
   aSICH                   17                                       

BMI -- body mass index; SD -- standard deviation; SICH -- symptomatic intracerebral hemorrhage; aSICH -- asymptomatic intracerebral hemorrhage.

###### 

Association of *EDN1* polymorphisms with ICH patients susceptibility.

  Genotype/allele   Cases n=154 (%)   Controls n=168 (%)   *P* value   OR (95% CI)                *P* value[\*](#tfn2-medscimonit-26-e919110){ref-type="table-fn"}   OR (95% CI)[\*](#tfn2-medscimonit-26-e919110){ref-type="table-fn"}
  ----------------- ----------------- -------------------- ----------- -------------------------- ------------------------------------------------------------------ --------------------------------------------------------------------
  rs5370                                                                                                                                                             
   GG               98 (63.64)        116 (69.05)          --          --                         --                                                                 --
   GT               51 (33.12)        49 (29.17)           0.389       1.232 (0.766--1.982)       0.384                                                              1.238 (0.766--2.001)
   TT               5 (3.25)          3 (1.79)             0.352       1.973 (0.460--8.464)       0.420                                                              1.832 (0.421--7.971)
   G                247 (80.19)       281 (83.63)          --          --                         --                                                                 --
   T                61 (19.81)        55 (16.37)           0.257       1.262 (0.844--1.887)       0.274                                                              1.253 (0.836--1.879)
   *P*~HWE~         --                0.40                                                                                                                           
  rs6458155                                                                                                                                                          
   TT               16 (10.39)        32 (19.05)           --          --                         --                                                                 --
   CT               76 (49.35)        80 (47.62)           0.061       1.900 (0.965--3.740)       0.065                                                              1.904 (0.960--3.777)
   CC               62 (40.26)        56 (33.33)           **0.025**   **2.214 (1.099--4.461)**   **0.028**                                                          **2.217 (1.092--4.500)**
   T                108 (35.06)       144 (42.86)          --          --                         --                                                                 --
   C                200 (64.94)       192 (57.14)          **0.043**   **1.389 (1.010--1.910)**   **0.046**                                                          **1.386 (1.005--1.910)**
   *P*~HWE~         --                0.72                                                                                                                           

Adjusted by age, gender and BMI; OR -- odds ratios; 95% CI -- 95% confidence interval.
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